Jefferies Group LLC
- SEC CIK
- 0001084580
- Latest filing
- Sep 21, 2023
SAGE holding history
Sage Therapeutics, Inc. in every 13F filed by Jefferies Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SAGE overviewAll 13F holders of SAGEFull Q3 2022 holdings
- Shares (Q3 2022)
- 9,250
- Value
- $362.2K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 9,250 | $362.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 9,250 | $298.8K | <0.1% | +4,750+105.6% | Added | Holders |
| Q1 2022 | 4,500 | $148.9K | <0.1% | +1,994+79.6% | Added | Holders |
| Q4 2021 | 2,506 | $106.6K | <0.1% | −1,494−37.4% | Reduced | Holders |
| Q3 2021 | 4,000 | $177.2K | <0.1% | −20,878−83.9% | Reduced | Holders |
| Q2 2021 | 24,878 | $1.41M | <0.1% | +5,878+30.9% | Added | Holders |
| Q1 2021 | 19,000 | $1.42M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.